John Lindsay McCall

Title: John Lindsay McCall: Innovator in Colorectal Cancer Treatment

Introduction

John Lindsay McCall is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of cancer treatment, particularly focusing on colorectal cancer. With a total of 2 patents, his work emphasizes the importance of genetic markers in predicting cancer prognosis.

Latest Patents

McCall's latest patents revolve around methods for treating colorectal cancer using prognostic genetic markers. These inventions relate to prognostic signatures, compositions, and methods for determining the prognosis of cancer in patients. Specifically, they focus on the use of genetic markers to predict the prognosis of colorectal cancer. The inventions include methods for predicting the likelihood of long-term survival of cancer patients, determining treatment regimes, and preparing treatment modalities. Additionally, they encompass kits and devices designed to facilitate these methods.

Career Highlights

Throughout his career, McCall has worked with various companies, including Pacific Edge Limited and Pacific Edge Biotechnology Limited. His experience in these organizations has allowed him to develop and refine his innovative approaches to cancer treatment.

Collaborations

Some of McCall's notable coworkers include Hjalmar Nekarda and Jan Friederichs. Their collaboration has likely contributed to the advancements in the field of cancer research and treatment.

Conclusion

John Lindsay McCall's work in developing methods for treating colorectal cancer using genetic markers showcases his dedication to improving patient outcomes. His innovative patents and collaborations highlight the importance of research in the fight against cancer.